Newlink Genetics reported 8.67M in Operating Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agenus AGEN:US $ 77.12M 24.04M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Capricor Therapeutics CAPR:US $ 4.97M 232.81K
Celldex Therapeutics CLDX:US $ 16.92M 404K
Eli Lilly And LLY:US $ 5336.7M 313.6M
Idera Pharmaceuticals IDRA:US $ 7.56M 2.47M
Intrexon XON:US $ 49.25M 7.06M
Merk MRK:US $ 9905M 839M
Nektar Therapeutics NKTR:US $ 138.54M 5.5M
Newlink Genetics NLNK:US 8.67M 57K
Pfizer PFE:US $ 13063M 3998M
Prothena PRTA:US 32.12M 147K
Sarepta Therapeutics SRPT:US $ 331.66M 32.87M
Vascular Biogenics VBLT:US 8.21M 1.68M
YTE INCY:US $ 564.87M 58.95M